Prospective post-marketing surveillance study of Prevenar [pneumococcal 7 valent CRM197 vaccine conjugate] in high-risk children aged 2 to 5 years

Trial Profile

Prospective post-marketing surveillance study of Prevenar [pneumococcal 7 valent CRM197 vaccine conjugate] in high-risk children aged 2 to 5 years

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Dec 2007

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 07 Dec 2007 Status change from in progress to completed.
    • 25 May 2007 Status changed from recruiting to in progress.
    • 31 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top